FDA Approves Linzess to Treat Constipation in Children, Teens

WEDNESDAY, June 14, 2023 -- The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation. The approval was based on data from 328 participants...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news